Effect of metformin on the proliferation, migration, and MMP-2 and -9 expression of human umbilical vein endothelial cells
Open Access
- 12 January 2012
- journal article
- research article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 5 (4), 1068-1074
- https://doi.org/10.3892/mmr.2012.753
Abstract
Recent epidemiological studies have demonstrated that metformin lowers the risk of several types of cancer in diabetic patients. Matrix metalloproteinases (MMPs) play a crucial role in the degradation of the vascular basement membrane extracellular matrix proteins, thereby promoting endothelial cell invasion, migration and angiogenesis in the incidence and progression of tumors. The aim of this study was to investigate the effects of metformin on human umbilical vein endothelial cell (HUVEC) proliferation and migration, as well as on MMP-2 and MMP-9 expression. Cell proliferation was determined by cell counting and MTT colorimetric assays. Cell migration was assessed by the wound repair method. Quantitative real-time reverse transcription PCR was performed to quantify the mRNA expression of MMPs. Metformin at concentrations of 0.5-3.0 mM effectively reduced the number of endothelial cells by 55-55%, without being cytotoxic to the cells. Similarly, cell proliferation and migration were markedly inhibited by metfonnin. In addition, treatment with metformin demonstrated a strong (P<0.001) suppressive effect on the mRNA levels of MMP-2 and -9 in the endothelial cells. The inhibitory effects of metformin on endothelial cell number, migration, and MMP expression were reversed partially by compound C, which is an inhibitor of AMP-activated protein kinase (AMPK). The present study reports that metformin considerably inhibited the proliferation, migration, and MMP-2 and -9 expression of HUVECs, and the effect was partially AMPK-dependent. The obtained findings provide a molecular rationale, whereby metformin can exert anticancer effects.Keywords
This publication has 46 references indexed in Scilit:
- AMP-activated Protein Kinase Suppresses Matrix Metalloproteinase-9 Expression in Mouse Embryonic FibroblastsOnline Journal of Public Health Informatics, 2011
- Metformin Prevents Tobacco Carcinogen–Induced Lung TumorigenesisCancer Prevention Research, 2010
- Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase‐9 activation through a calcium and protein kinase Cα‐dependent pathway: phorbol‐12‐myristate‐13‐acetate‐induced/extracellular signal‐regulated kinase/activator protein‐1British Journal of Pharmacology, 2010
- Antidiabetic Therapies Affect Risk of Pancreatic CancerGastroenterology, 2009
- Metformin use and prostate cancer in Caucasian men: results from a population-based case–control studyCancer Causes & Control, 2009
- AMP-Activated Protein Kinase Promotes the Differentiation of Endothelial Progenitor CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Lopinavir impairs protein synthesis and induces eEF2 phosphorylation via the activation of AMP‐activated protein kinaseJournal of Cellular Biochemistry, 2008
- LKB1 modulates lung cancer differentiation and metastasisNature, 2007
- 5′-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor MicroenvironmentsMolecular and Cellular Biology, 2006
- AMP‐activated protein kinase – development of the energy sensor conceptJournal Of Physiology-London, 2006